Fagron SA (ARSUF)
18.59
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Fagron Debt to Equity Ratio: 0.7009 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7009 |
| June 30, 2023 | 0.7895 |
| December 31, 2022 | 0.8803 |
| June 30, 2022 | 1.020 |
| December 31, 2021 | 0.9279 |
| June 30, 2021 | 1.091 |
| December 31, 2020 | 1.268 |
| June 30, 2020 | 1.666 |
| December 31, 2019 | 1.472 |
| June 30, 2019 | 1.575 |
| December 31, 2018 | 1.599 |
| June 30, 2018 | 1.885 |
| December 31, 2017 | 1.633 |
| June 30, 2017 | 3.339 |
| December 31, 2016 | 3.867 |
| Date | Value |
|---|---|
| June 30, 2016 | 5.869 |
| December 31, 2015 | -8.925 |
| June 30, 2015 | 3.191 |
| December 31, 2014 | 3.590 |
| June 30, 2014 | 3.482 |
| December 31, 2013 | 2.760 |
| June 30, 2013 | 1.799 |
| December 31, 2012 | 1.260 |
| June 30, 2012 | 1.273 |
| December 31, 2011 | 1.185 |
| June 30, 2011 | 1.115 |
| December 31, 2010 | 1.058 |
| June 30, 2010 | 0.8971 |
| December 31, 2009 | 0.7628 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7009
Minimum
Dec 2023
1.666
Maximum
Jun 2020
1.139
Average
1.056
Median
Debt to Equity Ratio Benchmarks
| uniQure NV | 0.49 |
| ProQR Therapeutics NV | 0.1037 |
| Merus NV | 0.00 |
| argenx SE | 0.00 |
| Pharming Group | 0.6327 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.113B |
| Total Liabilities (Quarterly) | 596.17M |
| Shareholders Equity (Quarterly) | 512.60M |
| Current Ratio | 1.917 |
| Net Debt Paydown Yield | 0.92% |